RE:RE:RE:RE:Ceapro will go bankrupt in the end?tigerpro wrote: The Q1 is bad, the CEO said the big client was re-ordering. The Q2 is even wose, then I realized the management was lying agian as usual. Also, I realized JNJ may be changing its old product lines. This is the inevitable risk, sooner or later.
Why create a new Stockhouse profile and then lie to people?
After Q1 CZO said it expected re-ordering upon the completion of the spin-out of a major client.
News release:
"Despite the fact that inflation is prevailing on all fronts and that sales were mainly impacted by lower orders from USA for avenanthramides, for which we expect the reordering pattern should resume upon completion of re-organization resulting from the spinoff of the consumer division from one major customer, management believes the prospects for the Company remain positive. " After Q2 CZO expected reordering shortly:
"Our business remains solid, and we believe we are positioned now for the return of a more consistent re-ordering pattern from one of our major customers." "Despite a slower start to the year, our business remains solid, and we expect the reordering pattern from one major customer to resume shortly." The seperation of Kenvue, who now owns Aveeno and Neutrogena, was only officially finalized on August 23, 2023.
Kenvue Becomes a Fully Independent Company Following Final Separation from Johnson & Johnson